Recent studies have uncovered that FOXN3 functions as a key player in multiple kinds of malignant tumors, such as papillary thyroid cancer [13], tongue squamous cell carcinoma [14], melanoma [15] and breast cancer [16]. Here, FOXN3 is linked to tongue squamous cell carcinoma.